 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Reiman E. on NEWS: Protective APP Mutation Found—Supports Amyloid Hypothesis, This elegant and important study finds an association between a rare APP variant and a lower... 13 Jul 2012.
|
|
|
 |
|
|
Langbaum J, Reiman E, Tariot P. on NEWS: News Flash: Colombian Families Come to Phoenix for Amyloid PET, We are so grateful for the interest of the New York Times in the efforts of the Alzheimer's... 5 Oct 2011.
|
|
|
|
|
|
Reiman E. on NEWS: Brain Aβ Patterns Linked to Brain Energy Metabolism, In these elegant and important studies, researchers from Washington University in St. Louis... 24 Sep 2010.
|
|
|
|
|
|
Reiman E. on LIVE DISCUSSION: Together at Last, Top Five Biomarkers Model Stages of AD, In this important article, Cliff Jack and his colleagues have done a wonderful job of... 20 Jan 2010.
|
|
|
|
|
|
Reiman E. on PAPER: Cohen AD. et al., 2009, In another important contribution to the field, University of Pittsburgh researchers correlated... 1 Dec 2009.
|
|
|
|
|
|
Reiman E. on PAPER: Hughes TF. et al., 2010, This prospective cohort study of Swedish twins supports the possibility that mid-life... 25 Nov 2009.
|
|
|
|
|
|
Reiman E. on LIVE DISCUSSION: Early Detection of Alzheimer Disease—A Virtual Town Hall Meeting, It Is Time to Make Alzheimer’s Prevention a National Priority
Alzheimer disease... 30 Jun 2008.
|
|
|
|
|
|
Reiman E. on NEWS: It Is Official: Autopsy Verifies Human PIB-Amyloid Connection, This case report demonstrates a correlation between PIB retention in the living human brain and... 24 Mar 2007.
|
|
|
|
|
|
Reiman E. on PAPER: Jorm AF. et al., 2007, This is the largest study of its kind and an impressive undertaking. The authors’ findings... 11 Jan 2007.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
